Transplant Diagnostics Market by Technology, Application, Products & Services - 2021 | MarketsandMarkets
Transplant Diagnostics Market report categories the global market by Products & Services (Instruments, Reagents), Application (Infectious Disease Testing, Blood Profiling), Technology (PCR, SSO-PCR, SSP-PCR, NGS, Sanger’s Sequencing, Microarray), End User
(EMAILWIRE.COM, November 28, 2017 ) Browse 66 market data tables and 55 figures spread through 183 pages and in-depth TOC on “Transplant Diagnostics Market - Global forecast 2021”
https://www.marketsandmarkets.com/Market-Reports/global-transplant-diagnostics-market-2531061.html
Early buyers will receive 10% customization on reports.
The global transplant diagnostics market is estimated to reach USD 4.36 Billion by 2021, growing at a CAGR of 7.0% during the forecast period. Factors such as the growing number of solid organ, tissue, and stem cell transplantation procedures; ongoing technological advancements in the field of genetics; and growing awareness among healthcare professionals about the benefits offered by molecular assay techniques are propelling the growth of the global market. High cost of transplant diagnostic products, limited medical reimbursements for organ donation & transplant procedures, and reluctance for organ donation among the public across developing & less-developed countries are the major factors restraining the growth of the market.
Emerging markets offer high growth opportunities for market players operating in the transplant diagnostics market. Rising incidence of chronic and infectious diseases, increasing awareness related to transplant diagnostic procedures, and continuously rising healthcare expenditure in the Asia-Pacific region are the key factors propelling the demand for transplant diagnostic products in emerging nations. In order to leverage the high growth opportunities in these emerging nations, leading market players are expanding their presence in these countries.
In 2015, Thermo Fisher Scientific, Inc. (U.S.) held the leadership position in the global transplant diagnostics market. Over the past three years, the company has adopted new product launches, product approvals, product enhancements, and strategic acquisitions and agreements as its key business strategies to ensure its dominance in this market. Bio-Rad Laboratories, Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Immucor, Inc. (U.S.), bioMérieux S.A. (France), Becton Dickinson and Company (U.S.), CareDx (U.S.), Illumina, Inc. (U.S.), and GenDx (Netherlands) are the other key players in the market.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
https://www.marketsandmarkets.com/Market-Reports/global-transplant-diagnostics-market-2531061.html
Early buyers will receive 10% customization on reports.
The global transplant diagnostics market is estimated to reach USD 4.36 Billion by 2021, growing at a CAGR of 7.0% during the forecast period. Factors such as the growing number of solid organ, tissue, and stem cell transplantation procedures; ongoing technological advancements in the field of genetics; and growing awareness among healthcare professionals about the benefits offered by molecular assay techniques are propelling the growth of the global market. High cost of transplant diagnostic products, limited medical reimbursements for organ donation & transplant procedures, and reluctance for organ donation among the public across developing & less-developed countries are the major factors restraining the growth of the market.
Emerging markets offer high growth opportunities for market players operating in the transplant diagnostics market. Rising incidence of chronic and infectious diseases, increasing awareness related to transplant diagnostic procedures, and continuously rising healthcare expenditure in the Asia-Pacific region are the key factors propelling the demand for transplant diagnostic products in emerging nations. In order to leverage the high growth opportunities in these emerging nations, leading market players are expanding their presence in these countries.
In 2015, Thermo Fisher Scientific, Inc. (U.S.) held the leadership position in the global transplant diagnostics market. Over the past three years, the company has adopted new product launches, product approvals, product enhancements, and strategic acquisitions and agreements as its key business strategies to ensure its dominance in this market. Bio-Rad Laboratories, Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Immucor, Inc. (U.S.), bioMérieux S.A. (France), Becton Dickinson and Company (U.S.), CareDx (U.S.), Illumina, Inc. (U.S.), and GenDx (Netherlands) are the other key players in the market.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact Information:
MarketsandMarkets™
Mr. Rohan
Tel: 1-888-600-6441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
MarketsandMarkets™
Mr. Rohan
Tel: 1-888-600-6441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results